# NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

> **NCT00014677** · PHASE2 · COMPLETED · sponsor: **Neurocrine Biosciences**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **BIOLOGICAL:** interleukin-4 PE38KDEL cytotoxin
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00014677
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2002-09
- **Final completion:** 2008-07
- **Target enrollment:** — (—)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014677, "NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00014677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*